Meeting: 2017 ASCO Annual Meeting Track: Lung Cancer – Non-small Cell Metastatic Abstract number: LBA 9008 Citation: J Clin Oncol 35, 2017 (suppl; abstr LBA 9008) Authors: Alice Tsang Shaw, Solange Peters, Tony Mok, et al. Background: Alectinib, a TKI targeting ALK, has shown robust efficacy in crizotinib naive/resistant ALK+...
Pro zobrazení tohoto obsahu je třeba být přihlášen.